• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

背景发生率的异质性对原子弹幸存者实体瘤辐射剂量反应推断的影响。

Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors.

机构信息

Departments of Statistics.

Department of Preventive Medicine, College of Medicine, Keimyung University, Daegu, Korea.

出版信息

Radiat Res. 2019 Aug;192(4):388-398. doi: 10.1667/RR15127.1. Epub 2019 Jul 29.

DOI:10.1667/RR15127.1
PMID:31355713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6827345/
Abstract

A recent analysis of solid cancer incidence in the Life Span Study of atomic bomb survivors (Hiroshima and Nagasaki, Japan) found evidence of a nonlinear, upwardly curving radiation dose response among males but not among females. Further analysis of this new and unexpected finding was necessary. We used two approaches to investigate this finding. In one approach, we excluded individual cancer sites or groups of sites from all solid cancers. In the other approach, we used joint analysis to allow for heterogeneity in background-rate parameters across groups of cancers with dissimilar trends in background rates. Exclusion of a few sites led to the disappearance of curvature among males in the remaining collection of solid cancers; some of these influential sites have unique features in their background age-specific incidence that are not captured by a background-rate model fit to all solid cancers combined. Exclusion of a few sites also led to an appearance of curvature among females. Misspecification of background rates can cause bias in inference about the shape of the dose response, so heterogeneity of background rates might explain at least part of the all solid cancer dose-response difference in curvature between males and females. We conclude that analysis based on all solid cancers as a single outcome is not the optimal method to assess radiation risk for solid cancer in the Life Span Study; joint analysis with suitable choices of cancer groups might be preferable by allowing for background-rate heterogeneity across sites while providing greater power to assess radiation risk than analyses of individual sites.

摘要

最近对原子弹幸存者寿命研究(日本广岛和长崎)中实体癌发病率的分析发现,男性而非女性的辐射剂量反应呈非线性、向上弯曲。需要进一步分析这一新的、出乎意料的发现。我们使用两种方法来研究这一发现。一种方法是将个体癌症部位或癌症部位组从所有实体癌中排除。另一种方法是使用联合分析,允许具有不同背景率趋势的癌症组中的背景率参数存在异质性。排除少数几个部位会导致男性在剩余的实体癌集合中弯曲消失;这些有影响力的部位中的一些在其背景特定年龄的发病率方面具有独特的特征,这些特征无法通过拟合所有实体癌的背景率模型来捕捉。排除少数几个部位也会导致女性出现弯曲。背景率的错误指定会导致对剂量反应形状的推断产生偏差,因此背景率的异质性可能至少部分解释了男性和女性在所有实体癌弯曲方面的剂量反应差异。我们得出结论,基于所有实体癌作为单一结果的分析不是评估寿命研究中实体癌辐射风险的最佳方法;通过允许跨部位的背景率异质性,同时比分析单个部位提供更大的评估辐射风险的能力,与合适的癌症组进行联合分析可能更为可取。

相似文献

1
Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors.背景发生率的异质性对原子弹幸存者实体瘤辐射剂量反应推断的影响。
Radiat Res. 2019 Aug;192(4):388-398. doi: 10.1667/RR15127.1. Epub 2019 Jul 29.
2
Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009.1958-2009 年间原子弹幸存者寿命研究中的所有实体癌死亡率和发病率剂量反应比较。
Radiat Res. 2022 May 1;197(5):491-508. doi: 10.1667/RADE-21-00059.1.
3
Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.原子弹爆炸幸存者寿命研究中的实体癌发病率:1958 - 2009年
Radiat Res. 2017 May;187(5):513-537. doi: 10.1667/RR14492.1. Epub 2017 Mar 20.
4
Cancer and non-cancer effects in Japanese atomic bomb survivors.日本原子弹幸存者中的癌症及非癌症影响。
J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19.
5
Radiation-Related Risk of Cancers of the Upper Digestive Tract among Japanese Atomic Bomb Survivors.日本原子弹幸存者中与辐射相关的上消化道癌症风险。
Radiat Res. 2019 Sep;192(3):331-344. doi: 10.1667/RR15386.1. Epub 2019 Jul 29.
6
Solid cancer incidence in atomic bomb survivors: 1958-1998.原子弹爆炸幸存者实体癌发病率:1958 - 1998年
Radiat Res. 2007 Jul;168(1):1-64. doi: 10.1667/RR0763.1.
7
Radiation and Risk of Liver, Biliary Tract, and Pancreatic Cancers among Atomic Bomb Survivors in Hiroshima and Nagasaki: 1958-2009.广岛和长崎原子弹幸存者中辐射与肝、胆道和胰腺癌症风险:1958-2009 年。
Radiat Res. 2019 Sep;192(3):299-310. doi: 10.1667/RR15341.1. Epub 2019 Jul 10.
8
Ionizing radiation and kidney cancer among Japanese atomic bomb survivors.日本原子弹幸存者中的电离辐射与肾癌。
Radiat Res. 2010 Jun;173(6):837-42. doi: 10.1667/RR2096.1.
9
Effects of radiation on the incidence of prostate cancer among Nagasaki atomic bomb survivors.长崎原子弹幸存者中辐射对前列腺癌发病率的影响。
Cancer Sci. 2013 Oct;104(10):1368-71. doi: 10.1111/cas.12234. Epub 2013 Aug 12.
10
Selection of reference groups in the Life Span Study of atomic bomb survivors.在原子弹幸存者寿命研究中参考组的选择。
Eur J Epidemiol. 2017 Dec;32(12):1055-1063. doi: 10.1007/s10654-017-0337-9. Epub 2017 Dec 4.

引用本文的文献

1
A note on potential gains in precision of radiation risk estimates from joint analysis.关于从联合分析中提高辐射风险估计精度的说明。
Sci Rep. 2024 Nov 5;14(1):26750. doi: 10.1038/s41598-024-76920-x.
2
Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases.影响背景发病率计算的因素:跨国际观察性数据库网络的系统实证评估
Front Pharmacol. 2022 Apr 26;13:814198. doi: 10.3389/fphar.2022.814198. eCollection 2022.
3
Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009.1958-2009 年间原子弹幸存者寿命研究中的所有实体癌死亡率和发病率剂量反应比较。
Radiat Res. 2022 May 1;197(5):491-508. doi: 10.1667/RADE-21-00059.1.
4
Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.考虑剂量测量误差后,基于日本原子弹幸存者寿命研究数据预测的癌症和循环系统疾病终生死亡率。
Radiat Res. 2020 Sep 16;194(3):259-276. doi: 10.1667/RR15571.1.
5
High CT doses return to the agenda.高CT剂量问题再度被提上议程。
Radiat Environ Biophys. 2020 Mar;59(1):3-7. doi: 10.1007/s00411-019-00827-9. Epub 2019 Dec 16.

本文引用的文献

1
Radiation Risks of Uterine Cancer in Atomic Bomb Survivors: 1958-2009.原子弹爆炸幸存者子宫癌的辐射风险:1958 - 2009年
JNCI Cancer Spectr. 2018 Oct;2(4):pky081. doi: 10.1093/jncics/pky081. Epub 2019 Feb 8.
2
Radiation risk of incident colorectal cancer by anatomical site among atomic bomb survivors: 1958-2009.以解剖部位分类的原子弹幸存者新发结直肠癌的辐射风险:1958-2009 年。
Int J Cancer. 2020 Feb 1;146(3):635-645. doi: 10.1002/ijc.32275. Epub 2019 Apr 3.
3
Incidence of Breast Cancer in the Life Span Study of Atomic Bomb Survivors: 1958-2009.原子弹幸存者寿命研究中的乳腺癌发病率:1958-2009 年。
Radiat Res. 2018 Oct;190(4):433-444. doi: 10.1667/RR15015.1. Epub 2018 Jul 25.
4
Selection of reference groups in the Life Span Study of atomic bomb survivors.在原子弹幸存者寿命研究中参考组的选择。
Eur J Epidemiol. 2017 Dec;32(12):1055-1063. doi: 10.1007/s10654-017-0337-9. Epub 2017 Dec 4.
5
Effect of follow-up period on minimal-significant dose in the atomic-bomb survivor studies.原子弹幸存者研究中随访期对最小显著剂量的影响。
Radiat Environ Biophys. 2018 Mar;57(1):83-88. doi: 10.1007/s00411-017-0720-7. Epub 2017 Nov 21.
6
Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009.日本原子弹幸存者中的肺癌、喉癌及其他呼吸道癌症发病率:1958年至2009年的最新分析
Radiat Res. 2017 May;187(5):538-548. doi: 10.1667/RR14583.1. Epub 2017 Mar 21.
7
Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.原子弹爆炸幸存者寿命研究中的实体癌发病率:1958 - 2009年
Radiat Res. 2017 May;187(5):513-537. doi: 10.1667/RR14492.1. Epub 2017 Mar 20.
8
DS02R1: Improvements to Atomic Bomb Survivors' Input Data and Implementation of Dosimetry System 2002 (DS02) and Resulting Changes in Estimated Doses.DS02R1:原子弹幸存者输入数据的改进、2002年剂量测定系统(DS02)的实施以及估计剂量的相应变化
Health Phys. 2017 Jan;112(1):56-97. doi: 10.1097/HP.0000000000000598.
9
Statistics of bone sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.日本骨肉瘤统计:来自日本骨与软组织肿瘤登记处的报告。
J Orthop Sci. 2017 Jan;22(1):133-143. doi: 10.1016/j.jos.2016.10.006. Epub 2016 Nov 12.
10
Thyroid Growth and Cancer.甲状腺生长与癌症。
Eur Thyroid J. 2015 Sep;4(3):164-73. doi: 10.1159/000437263. Epub 2015 Aug 26.